Effects of neural therapy on quality of life in patients suffering from Raynaud syndrome

Our study is the first to evaluate SGB as a complementary treatment in addition to conventional standard care and employ subjective and objective outcome measurements, in a group of patients with Raynaud syndrome. These promising findings are an indicator for further research.